TickerFacts.

Staar Surgical Co (STAA): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-30, 2023-12-29 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$40.05M
Year ended 2026-01-02, Fiscal 2025
$38.32M
Trailing 12 months to 2026-07-03
$45.32M2010-01-01: $5.89M2010-12-31: $5.72M2011-12-30: $5.87M2012-12-28: $6.44M2014-01-03: $6.71M2015-01-02: $12.36M2016-01-01: $14.76M2016-12-30: $20.67M2017-12-29: $20.04M2018-12-28: $22.03M2020-01-03: $25.30M2021-01-01: $31.92M2021-12-31: $33.86M2022-12-30: $35.98M2023-12-29: $40.48M2024-12-27: $45.32M2026-01-02: $40.05M$40.05M
2010-01-01 R&D Expense (USD) 2026-01-02
Period endedR&D ExpenseChange YoYSource filing
2026-01-02, Fiscal 2025$40.05M-11.6%2026-03-03, From 2024-12-28
2024-12-27$45.32M+12.0%2026-03-03, From 2023-12-30
2023-12-29$40.48Mn/c2026-03-03, From 2022-12-31
2022-12-30$35.98M+6.3%2025-02-21, From 2022-01-01
2021-12-31$33.86M+6.1%2024-02-27, From 2021-01-02
2021-01-01, Fiscal 2020$31.92M+26.2%2023-02-23, From 2020-01-04
2020-01-03, Fiscal 2019$25.30M+14.8%2022-02-23, From 2018-12-29
2018-12-28$22.03M+9.9%2021-02-24, From 2017-12-30
2017-12-29$20.04M-3.0%2020-02-26, From 2016-12-31
2016-12-30$20.67Mn/c2019-02-21, From 2016-01-02
2016-01-01, Fiscal 2015$14.76M+19.4%2018-02-28, From 2015-01-03
2015-01-02, Fiscal 2014$12.36M+84.3%2017-03-02, From 2014-01-04
2014-01-03, Fiscal 2013$6.71M+4.1%2016-03-11, From 2012-12-29
2012-12-28$6.44M+9.8%2015-03-13, From 2011-12-31
2011-12-30$5.87M+2.5%2014-03-12, From 2011-01-01
2010-12-31$5.72Mn/a2013-03-12, From 2010-01-01
2010-01-01, Fiscal 2009$5.89Mn/a2012-03-08, From 2009-01-04

R&D Expense at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Staar Surgical Co (STAA)2026-01-02$40.05M-11.6%
RxSight, Inc. (RXST)2025-12-31$38.55M+12.2%
Cooper Companies, Inc. (COO)2025-10-31$172.20M+11.0%
Bausch & Lomb Corp (BLCO)2025-12-31$371.00M+8.2%
Innovative Eyewear Inc (LUCYW)2025-12-31$725.4K-11.5%

Compare STAA, RXST, COO, BLCO side by side · Screen every company in Ophthalmic Goods ↗